| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
180 Life Sciences Corp.
13D/A
ETHZ · 68236V302
|
52.8% |
4/11/2025
Event 3/27/2025
|
||||
| Anthony Brian Goodman | 52.8% | |||||
| Elray Resources, Inc. | 52.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.